Will Coronavirus Ever Go Away? Here ’s What One of the WHO’s Top Experts Thinks
Dr. Bruce Aylward has almost 30 years experience in fighting polio, Ebola and other diseases, and now, he’s turned his attention to stopping the spread of COVID-19. Aylward, the senior adviser to the Director-General of the World Health Organization (WHO), is one of the world’s top officials in charge of fighting the coronavirus pandemic. The doctor, who lead a joint WHO mission to China in February to study the effectiveness of the coronavirus response in the country, has seen firsthand the measures Beijing took to fight the virus. Now he’s sharing what he learned with governments and communicating with ...
Source: TIME: Health - March 23, 2020 Category: Consumer Health News Authors: Amy Gunia Tags: Uncategorized COVID-19 overnight Source Type: news

Trials to begin on Covid-19 vaccine in UK next month
Researchers hope to conduct animal tests next week and safety trials as early as next monthCoronavirus – latest updatesSee all our coronavirus coverageA massive effort is under way to develop a UK vaccine for coronavirus within months and make it available to save lives before the end of the year, the Guardian has learned.Researchers at Oxford University, led by Prof Sarah Gilbert, are planning a safety trial on humans of what is expected to be the UK ’s first coronavirus vaccine next month. Provided that it goes smoothly, they will move directly into a larger trial to assess how effective the vaccine is at pro...
Source: Guardian Unlimited Science - March 19, 2020 Category: Science Authors: Ian Sample Science editor Tags: Health Coronavirus outbreak Vaccines and immunisation Medical research Science Infectious diseases UK news Ebola Source Type: news

UN health chief announces global ‘solidarity trial’ to jumpstart search for COVID-19 treatment
Just 60 days after the genetic sequence of COVID-19 was shared by China, the first vaccine trial has begun, the UN health chief said on Wednesday, calling it “an incredible achievement” and urging the world to maintain “the same spirit of solidarity” that has helped fight Ebola. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - March 18, 2020 Category: International Medicine & Public Health Source Type: news

COVID-19 Puts the World Health Organization ’s Emergency Use Listing (EUL) to Work
The World Health Organization’s Emergency Use Listing (EUL) provides an approach for assessing medicines, vaccines, and diagnostics that could help address an outbreak classified by the WHO as a Public Health Emergency of International Concern (PHEIC). Robyn Meurant, executive director, regulatory services, IVDs and medical devices for NSF International, describes the EUL as “akin to the U.S. FDA’s Emergency Use Authorization” and says it could help countries that are “without great means to do testing.” ...
Source: MDDI - March 16, 2020 Category: Medical Devices Authors: Daphne Allen Tags: Regulatory and Compliance Source Type: news

Trump ’s State of Emergency Is an Admission of Failure by the U.S. Government
President Donald Trump’s declaration of a national emergency is designed to speed federal support to parts of America that are struggling to prepare for a coming surge of COVID-19 cases, unlocking $50 billion in aid, giving hospitals and doctors more freedom to handle a potential tsunami of sick patients and scrambling to make tests available. In a Rose Garden press conference Friday, Trump presented the emergency measures as proof that, “No nation is more prepared or more equipped to face down this crisis.” But for epidemiologists, medical experts and current and former U.S. public health officials, the ...
Source: TIME: Health - March 13, 2020 Category: Consumer Health News Authors: W.J. Hennigan Tags: Uncategorized COVID-19 Source Type: news

Johnson & Johnson Announces Collaboration with the Beth Israel Deaconess Medical Center to Accelerate COVID-19 Vaccine Development
NEW BRUNSWICK, N.J., March 13, 2020 – Johnson & Johnson today announced that its Janssen Pharmaceutical Companies have entered a collaboration with the Beth Israel Deaconess Medical Center (BIDMC) to support the development of a preventive vaccine candidate for COVID-19. The parties have commenced preclinical testing of multiple vaccine prospects, with the aim to identify by the end of the month a COVID-19 vaccine candidate for clinical trials.Janssen is optimistic that, in collaboration with multiple global strategic partners, it can initiate a Phase 1 clinical study of a potential vaccine candidate by the end o...
Source: Johnson and Johnson - March 13, 2020 Category: Pharmaceuticals Tags: Our Company Source Type: news

Don ’t Blame China. The Next Pandemic Could Come from Anywhere
The northern side of Chatuchak Weekend Market feels a bit like Noah has hit hard times and decided to offload the entire contents of his Ark. In wooden cages, bright-plumed fighting cocks squawk and peck. Around the corner are snakes in plastic takeout containers, prices scrawled on them in sharpie. Hairless squirrel kits snooze in a pile as a meerkat and giant iguana gaze on. A pygmy monkey leaps about with a furious scowl, perhaps indignant at the 30,000 baht ($950) price tag fixed to his enclosure. Across the narrow alleyway, a lynx prowls restlessly within its cage. “He’s 250,000 baht [$7,900],” says ...
Source: TIME: Health - March 11, 2020 Category: Consumer Health News Authors: Charlie Campbell / Bangkok Tags: Uncategorized COVID-19 News Desk overnight Source Type: news

Coronavirus Drug and Vaccine Studies Are Recruiting Their First Volunteers
This study, says Kalil, is also designed to be more flexible than most drug trials. “This is not just a remdesivir trial,” he says. “It will test as many [COVID-19] therapies as possible, and remdesivir is just the first. Let’s say a couple of months from now, we realize that remdesivir is a good drug, that it works better than placebo…. Then patients receiving the placebo would be offered the drug and we would move on to test another drug. If remdesivir turns out not to be effective, then we would remove it from the study and bring another drug to test against placebo. It’s a dynamic, ...
Source: TIME: Science - March 10, 2020 Category: Science Authors: Alice Park Tags: Uncategorized COVID-19 Infectious Disease Source Type: news

Coronavirus Drug and Vaccine Studies Are Recruiting Their First Volunteers
This study, says Kalil, is also designed to be more flexible than most drug trials. “This is not just a remdesivir trial,” he says. “It will test as many [COVID-19] therapies as possible, and remdesivir is just the first. Let’s say a couple of months from now, we realize that remdesivir is a good drug, that it works better than placebo…. Then patients receiving the placebo would be offered the drug and we would move on to test another drug. If remdesivir turns out not to be effective, then we would remove it from the study and bring another drug to test against placebo. It’s a dynamic, ...
Source: TIME: Health - March 10, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Infectious Disease Source Type: news

Coronavirus: Ten Reasons Why You Ought Not to Panic
This article is republished from The Conversation. Read the original article. The post Coronavirus: Ten Reasons Why You Ought Not to Panic appeared first on Inter Press Service. Excerpt: Ignacio López-Goñi is microbiologist and works in University of Navarra (Spain). The post Coronavirus: Ten Reasons Why You Ought Not to Panic appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - March 7, 2020 Category: International Medicine & Public Health Authors: Ignacio Lopez Goni Tags: Global Headlines Health Coronavirus Source Type: news

ACIP Recommends Preexposure Ebola Virus Vaccine
During the Feb. 26-27 meeting of the CDC's Advisory Committee on Immunization Practices, the group voted to recommend a preexposure vaccine against Ebola virus for adults. (Source: AAFP News)
Source: AAFP News - March 4, 2020 Category: Primary Care Source Type: news

CDC Panel Recommends Ebola Vaccine for Adults With Exposure Risk CDC Panel Recommends Ebola Vaccine for Adults With Exposure Risk
A CDC advisory committee recommended preexposure vaccination with the first-ever FDA-approved vaccine against Ebola virus, species Zaire ebolavirus, for three groups of high-risk adults.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 27, 2020 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

COVID-19 Vaccine Shipped, and Drug Trials Start
Moderna Therapeutics, a biotech company based in Cambridge, Mass., has shipped the first batches of its COVID-19 vaccine. The vaccine was created just 42 days after the genetic sequence of the COVID_19 virus, called SARS-CoV-2, was released by Chinese researchers in mid-January. The first vials were sent to the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) in Bethesda, MD, which will ready the vaccine for human testing as early as April. NIH scientists also began testing an antiviral drug called remdesivir that had been developed for Ebola, on a patient infec...
Source: TIME: Health - February 25, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Laboratory monkeys are infected with a lethal coronavirus in vaccine hunt
Researchers at the US National Institutes of Health tested an experimental antiviral drug, first created for Ebola, on 18 rhesus macaques. (Source: the Mail online | Health)
Source: the Mail online | Health - February 24, 2020 Category: Consumer Health News Source Type: news

Africa: Newly Licensed Vaccine, 'Milestone in the Fight' Against Ebola in Africa, UN Health Agency
[UN News] Four countries in Africa have licensed an Ebola vaccine to "cement hard-fought progress" in keeping their people safe from the deadly disease, the UN health agency said on Friday. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 15, 2020 Category: African Health Source Type: news

Africa: Four Countries in the African Region License Vaccine in Milestone for Ebola Prevention
[WHO] The Democratic Republic of the Congo (DRC), Burundi, Ghana and Zambia have licensed an Ebola vaccine, just 90 days after World Health Organization (WHO) prequalification. Registration of the vaccine is expected in additional countries in the coming weeks. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 15, 2020 Category: African Health Source Type: news

Newly licensed vaccine, ‘milestone in the fight’ against Ebola in Africa, UN health agency
Four countries in Africa have licensed an Ebola vaccine to “cement hard-fought progress” in keeping their people safe from the deadly disease, the UN health agency said on Friday. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - February 14, 2020 Category: International Medicine & Public Health Source Type: news

It ’s Not Too Late to Prepare for COVID-19
By Dr. Lisa Stone, Epidemiology Adviser ; Robert Salerno, Director, Global Health Security Publio Gonzalez, a biologist with the Gorgas Institute, holds a bat in Meteti, Panama, June 6, 2018, as part an Emerging Infectious Diseases Training Event (U.S. Air Force photo by Senior Airman Dustin Mullen).February 11, 2020A disease spillover event, when a virus moves from animal to human hosts, can cause significant human illness. The coronavirus (COVID-19) seems to have spilled over sometime in late 2019, at a wildlife market in Wuhan, China, leading to more than 40,000 confirmed cases and at least 910 reported deaths&nbs...
Source: IntraHealth International - February 11, 2020 Category: International Medicine & Public Health Authors: kseaton Tags: Infectious Diseases Global Health Security Source Type: news

Johnson & Johnson Announces Collaboration with U.S. Department of Health & Human Services to Accelerate Development of a Potential Novel Coronavirus Vaccine
NEW BRUNSWICK, N.J., February 11, 2020 – Johnson & Johnson today announced that its Janssen Pharmaceutical Companies will further expedite its investigational coronavirus vaccine program through an expanded collaboration with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health & Human Services. The collaborative partnership with BARDA builds on Johnson & Johnson’s multipronged response to the new coronavirus disease (COVID-19) outbreak. In addition to Janssen’s ef...
Source: Johnson and Johnson - February 11, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Coronavirus Researchers Are Using High-Tech Methods to Predict Where the Virus Might Go Next
As the deadly 2019-nCov coronavirus spreads, raising fears of a worldwide pandemic, researchers and startups are using artificial intelligence and other technologies to predict where the virus might appear next — and even potentially sound the alarm before other new, potentially threatening viruses become public health crises. “What we’re doing currently with Coronavirus is really trying to get an understanding of what’s happening on the ground through as many sources as we can get our hands on,” says John Brownstein, chief innovation officer at Boston Children’s Hospital and a professor...
Source: TIME: Health - February 11, 2020 Category: Consumer Health News Authors: Alejandro de la Garza Tags: Uncategorized 2019-nCoV coronavirus MSFTAI2019 onetime Source Type: news

The Coronavirus Outbreak Should Bring Out the Best in Humanity
Pandemics are perversely democratic. They’re nasty, lethal and sneaky, but they don’t discriminate. No matter your age, ethnicity, religion, gender, or nation, you’re a part of the pathogenic constituency. That shared vulnerability, and the resulting human collectivism—a universal response to a universal threat—is newly and vividly evident in the face of the now-global outbreak of the novel coronavirus known as 2019-nCoV. As of writing, there have been over 30,000 diagnosed cases and over 630 related deaths. A virus that emerged in a single city, Wuhan, China—indeed, in a single crowded ...
Source: TIME: Health - February 8, 2020 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized 2019-nCoV Infectious Disease Source Type: news

How Our Modern World Creates Outbreaks Like Coronavirus
“Everyone knows that pestilences have a way of recurring in the world,” observes Albert Camus in his novel The Plague. “Yet somehow we find it hard to believe in ones that crash down on our heads from a blue sky. There have been as many plagues as wars in history; yet plagues and wars always take people by surprise.” Camus was imagining a fictional outbreak of plague in 1948 in Oran, a port city in northwest Algeria. But at a time when the world is reeling from a very real microbial emergency sparked by the emergence of a novel coronavirus in Wuhan, central China, his observations are as pertinent a...
Source: TIME: Health - February 7, 2020 Category: Consumer Health News Authors: Mark Honigsbaum Tags: Uncategorized 2019-nCoV health ideas Source Type: news

Past Outbreaks Provide a Roadmap for U.S. Government Response to Coronavirus Threat
While the threat of the new coronavirus in the United States remains limited, a network of U.S. government agencies are already furiously ramping up efforts to contain the disease, should an outbreak occur. “We are working to keep the risk low,” said Health and Human Services Secretary Alex Azar, who is leading the federal government’s response, at a press conference Friday. So far, the overwhelming number of new cases of the virus, which originated in Wuhan, China, remain in China. There are only 11 confirmed cases in the U.S. The good news, some officials and infectious disease experts tell TIME, is t...
Source: TIME: Health - February 4, 2020 Category: Consumer Health News Authors: Abigail Abrams Tags: Uncategorized Source Type: news

The Future of Health Care in Rwanda Starts with a Strong Government Partnership
By Samson Radeny, Chief of party, Ingobyi Project, Rwanda ; Katherine Seaton, Editorial Officer Photo by Charles Harris for IntraHealth International.February 13, 2020Just a decade ago, Rwanda struggled to provide high-quality health services. But when the Millennium and Sustainable Development Goals pushed for change, Rwanda was focused, proactive, and determined to provide better for its 12 million people. Now, the country is an example of how hopes for better health care can become a reality.In the past two decades, the maternal mortality rate in Rwanda hasdropped from 1,071 to 210 deaths per 100,000 live births&n...
Source: IntraHealth International - February 4, 2020 Category: International Medicine & Public Health Authors: kseaton Tags: Infectious Diseases Maternal, Newborn, & Child Health Digital Health Leadership and Governance IntraHealth ' s 40th Anniversary Community Health Workers Source Type: news

Why We Are So Ill-Prepared for A Possible Pandemic Like Coronavirus
We were surprised in 2002 when a new coronavirus called SARS emerged from southern China and spread to 17 countries, causing more than 8,000 disease cases and nearly 800 deaths. We were surprised in 2009 when a new H1N1 influenza strain emerged in Mexico and caused worldwide panic. We were surprised in 2014 when Ebola virus broke out in three West African countries, with nearly 30,000 cases and more than 11,000 deaths. And here we are now, facing the 2019-nCoV coronavirus outbreak, on the verge of becoming a worldwide pandemic, wthin China reporting over 20,000 cases and nearly 500 deaths. Three years ago in a book, Deadl...
Source: TIME: Health - February 4, 2020 Category: Consumer Health News Authors: Michael T. Osterholm and Mark Olshaker Tags: Uncategorized 2019-nCoV health ideas Source Type: news

Doctors in China Are Starting Human Trials for a Coronavirus Treatment
China has kick-started a clinical trial to speedily test a drug for the novel coronavirus infection as the nation rushes therapies for those afflicted and scours for vaccines to protect the rest. Remdesivir, a new antiviral drug by Gilead Sciences Inc. aimed at infectious diseases such Ebola and SARS, will be tested by a medical team from Beijing-based China-Japan Friendship Hospital for efficacy in treating the deadly new strain of coronavirus, a hospital spokeswoman told Bloomberg News Monday. Trial for the drug will be conducted in the central Chinese city of Wuhan — ground zero of the viral outbreak that has so f...
Source: TIME: Health - February 3, 2020 Category: Consumer Health News Authors: Bloomberg Tags: Uncategorized 2019-nCoV Bloomberg onetime overnight Source Type: news

UK government pledges £20 million to help develop coronavirus vaccine
The funding will be used to support work to develop new vaccines for epidemics Related items fromOnMedica Warning on post-Brexit antibiotic use NHS review recommends making childhood vaccination more 'convenient' for parents Doctors can help overcome ‘vaccine hesitancy’ Global measles deaths reach historic low World ‘not prepared’ for Zika and Ebola (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 3, 2020 Category: UK Health Source Type: news

Wuhan Coronavirus Could Test the Trump Administration ’s Ability to Respond to a Crisis. Experts are Worried
As a new strain of coronavirus moves from the Wuhan province of China to other parts of the world, including the United States, public health leaders are advising government officials to embrace a deliberate, measured response. But with President Donald Trump at the helm of an often unpredictable administration, infectious disease and epidemic experts tell TIME they’re concerned about which officials will have the President’s ear, and how the Commander-in-Chief will manage his Twitter presence during a potential pandemic. On Friday, Health and Human Services Secretary Alex Azar announced that, against the advi...
Source: TIME: Health - January 31, 2020 Category: Consumer Health News Authors: Abigail Abrams Tags: Uncategorized 2019-nCoV Infectious Disease White House Source Type: news

‘There Are Sensible Voices That Are Emerging,’ How Scientists Are Using Social Media to Counter Coronavirus Misinformation
As a new form of coronavirus continues to infect a growing number of people around the world, medical professionals, scientists and big tech giants are fighting the spread of another contagion — misinformation. Just like a virus, it can be difficult to contain and many working in medical and scientific fields are using the very tools used to spread misinformation to counter it. Though so much misinformation is spread on platforms like Twitter and Facebook, Johns Hopkins Center for Health Security, and hundreds of other scientists and medical professionals who are studying the 2019 Novel Coronavirus, have been utilizi...
Source: TIME: Health - January 31, 2020 Category: Consumer Health News Authors: Jasmine Aguilera Tags: Uncategorized 2019-nCoV Infectious Disease onetime Source Type: news

The Coronavirus Outbreak Is Now a Public Health Emergency of International Concern. Here ’s What That Means
The World Health Organization (WHO) took the rare step Thursday of declaring a novel coronavirus outbreak that originated in Wuhan, China a public health emergency of international concern (PHEIC). But what does that actually mean? The WHO defines a PHEIC as an “extraordinary event” that “constitute[s] a public health risk to other States through the international spread of disease” and “potentially require[s] a coordinated international response.” Since that framework was defined in 2005—two years after another coronavirus, severe acute respiratory syndrome (SARS), spread through ...
Source: TIME: Health - January 30, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized 2019-nCoV public health Source Type: news

Johnson & Johnson Launches Multi-Pronged Response to Coronavirus Global Public Health Threat
NEW BRUNSWICK, N.J., January 29, 2020 – Johnson & Johnson today announced that it is mobilizing resources at its Janssen Pharmaceutical Companies to launch a multi-pronged response to the novel coronavirus (also known as 2019-nCoV or Wuhan coronavirus) outbreak. As part of this work, the Company has initiated efforts to develop a vaccine candidate against 2019-nCoV and broadly collaborate with others to screen a library of antiviral therapies. Identifying compounds with antiviral activity against 2019-nCoV may contribute to providing immediate relief to the current outbreak.“J&J has a long-standing comm...
Source: Johnson and Johnson - January 29, 2020 Category: Pharmaceuticals Tags: Our Company Source Type: news

Coronavirus Death Toll Rises to 80 as U.S. Prepares to Evacuate Americans From Wuhan
(BEIJING) — A new viral illness being watched with a wary eye around the globe accelerated its spread in China with 80 deaths so far, while the U.S. Consulate in the city at the epicenter announced it will evacuate its personnel and some other Americans aboard a charter flight. China’s health minister said the country was entering a “crucial stage” as “it seems like the ability of the virus to spread is getting stronger.” Ma Xiaowei declined to estimate how long it would take to bring the situation under control, but said travel restrictions and other strict measures should bring results...
Source: TIME: Health - January 27, 2020 Category: Consumer Health News Authors: Ken Moritsugu / AP Tags: Uncategorized China Infectious Disease onetime overnight Source Type: news

The Wuhan Coronavirus Is Spreading Fast. Will Doctors Be Able to Find a Treatment Before the Outbreak Ends?
Cases of a novel pneumonia-like illness that originated in Wuhan, China in December have now been confirmed in South Korea, Thailand, Japan, Taiwan, Macau—and, as of Jan. 21, the U.S. The virus’ geographic reach, as well as its newly discovered ability to spread via person-to-person contact, has health officials worried about the prospect of globals spread. As health officials scramble to learn more about the virus and is origins, researchers are simultaneously turning to the question of how to develop a vaccine or therapy that could help contain transmission worldwide—a feat that experts say is technical...
Source: TIME: Health - January 22, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Infectious Disease Source Type: news

Canada's Ebola vaccine almost didn't happen, new study reveals
Dalhousie University professor Matthew Herder accessed hundreds of government documents to find out what really happened as Canadian scientists tried for years to get the pharmaceutical industry interested in their discovery of an Ebola vaccine. (Source: CBC | Health)
Source: CBC | Health - January 17, 2020 Category: Consumer Health News Tags: News/Health Source Type: news

Demystifying Medicine 2020: Ebola: Then, Now and the NIH (National Institutes of Health)
Source: National Institutes of Health (NIH). Published: 1/14/2020. This one-hour, 44-minute presentation discusses how the National Institutes of Health (NIH) has been at the forefront in the global effort to prevent the spread of Ebola virus. NIH staff were deployed in western Africa during the 2015-2016 Ebola outbreak to provide primary care to those infected, and Ebola patients were received at the NIH Clinical Center. For many years prior, NIH scientists studied the natural reservoirs of emerging viruses such as Ebola virus and have elucidated the biology of Ebola virus infection, which has informed the creation of in...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - January 14, 2020 Category: International Medicine & Public Health Source Type: news

PREVAC-UP: The Partnership for Research on Ebola Vaccination extends follow-up
(INSERM (Institut national de la sant é et de la recherche m é dicale)) Public health efforts successfully stopped human-to-human transmission of Ebola virus in West Africa in 2016 after the worst Ebola outbreak in history. Pursuing and intensifying efforts to develop a safe and effective vaccination strategy against Ebola virus disease, with durable protection in all populations, including children, is vital. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 13, 2020 Category: Infectious Diseases Source Type: news

Congo-Kinshasa: World's Biggest Measles Outbreak in DR Congo Kills Thousands
[Deutsche Welle] The deadly virus has killed nearly three times as many people in the Democratic Republic of Congo as any Ebola outbreak. It's preventable with a vaccine. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 8, 2020 Category: African Health Source Type: news

Staged Ebola pandemic being prepped for America, followed by mandatory Ebola vaccines using LIVE viral strains
(Natural News) An effort is under way right now to harvest Ebola-infected subjects from African nations, then transport them to the U.S. border and have them cross into the United States as “human weapons” who will unleash Ebola on U.S. soil. This is part of the globalist effort to bring down the United States of... (Source: NaturalNews.com)
Source: NaturalNews.com - January 4, 2020 Category: Consumer Health News Source Type: news

CDC and FDA "tag-teaming" Ebola bioweapons psy-op to push dangerous vaccines as part of an Ebola outbreak mass theater operation
(Natural News) The federal government is ramping up its Ebola propaganda campaign once again with a new announcement from the Centers for Disease Control and Prevention (CDC) about a newly released Ebola rapid diagnostics test, which just so happens to coincide with the release of a new Food and Drug Administration (FDA)-approved Ebola vaccine that... (Source: NaturalNews.com)
Source: NaturalNews.com - January 1, 2020 Category: Consumer Health News Source Type: news

Ervebo (Ebola Zaire Vaccine, Live Suspension for Intramuscular Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 27, 2019 Category: Drugs & Pharmacology Source Type: news

Congo-Kinshasa: DRC - Fighting Measles in Ebola-Affected Areas
[MSF] Dr. Nicolas Peyraud, a Doctors Without Borders/M édecins Sans Frontières (MSF) vaccination referent, has just returned from several assignments in the Democratic Republic of Congo (DRC), where he helped to set up measles vaccination campaigns in collaboration with UNICEF and the Congolese Ministry of Health. In areas also affected by the Ebola o utbreak, providing care for children suffering from with measles and vaccinating those at risk of contracting the disease pose additional challenges fo (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 24, 2019 Category: African Health Source Type: news

Merck Says Ebola Vaccine to Be Available at Lowest Access Price for Poor Nations Merck Says Ebola Vaccine to Be Available at Lowest Access Price for Poor Nations
Merck& Co said on Friday it expects to make licensed doses of its recently approved Ebola vaccine available in the third quarter of 2020 and price the single-dose injection at the lowest possible access price for poor and middle-income countries.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 24, 2019 Category: Consumer Health News Tags: Public Health & Prevention News Source Type: news

‘We can beat Ebola but must prepare for what comes next,’ says Wellcome Trust head
Jeremy Farrar, a world expert on diseases, tells of the fight against the deadly virus that spread fear this decade – and how to prepare for the health battles to comeJeremy Farrar, head of the Wellcome Trust, has a straightforward view about the way doctors and scientists tackled thecurrent Ebola epidemic in the Democratic Republic of the Congo. “In four or five years, we have taken a disease that was absolutely terrifying and which had an enormously high death rate – more than 80% – and we have turned it, potentially, into something that is preventable and treatable.”The fact this has been d...
Source: Guardian Unlimited Science - December 22, 2019 Category: Science Authors: Robin McKie Tags: Ebola Infectious diseases Vaccines and immunisation Medical research World news Source Type: news

FDA Approves Ebola Vaccine For USe And Distribution In United States
Although Ebola is rare in the U. S., the vaccine ’s approval will help in world-wide efforts to prevent future Ebola outbreaks and deaths. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 21, 2019 Category: Pharmaceuticals Authors: Dana Dovey, Contributor Source Type: news

Merck says Ebola vaccine to be available at lowest access price for poor nations
Merck& Co said on Friday it expects to make licensed doses of its recently approved Ebola vaccine available in the third quarter of 2020 and price the single-dose injection at the lowest possible access price for poor and middle-income countries. (Source: Reuters: Health)
Source: Reuters: Health - December 20, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Clears First Vaccine Against Deadly Ebola Virus FDA Clears First Vaccine Against Deadly Ebola Virus
The live (attenuated) Ervebo vaccine protects against Ebola virus disease caused by the Zaire strain of the Ebola virus is approved in people 18 and older.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 20, 2019 Category: Drugs & Pharmacology Tags: Infectious Diseases News Alert Source Type: news

FDA OKs First Vaccine Against Deadly Ebola Virus FDA OKs First Vaccine Against Deadly Ebola Virus
The live (attenuated) Ervebo vaccine protects against Ebola virus disease caused by the Zaire strain of the Ebola virus is approved in people 18 and older.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 20, 2019 Category: Drugs & Pharmacology Tags: Infectious Diseases News Alert Source Type: news

FDA Gives First Ebola Vaccine for Adults the Green Light
FRIDAY, Dec. 20, 2019 -- The first Ebola vaccine approved by the U.S. Food and Drug Administration is a single-dose injection called Ervebo. The vaccine from Merck& Co. is approved to protect against the Zaire ebolavirus in people ages 18 years... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 20, 2019 Category: Pharmaceuticals Source Type: news

FDA Gives First Ebola Vaccine for Adults the Green Light
The vaccine from Merck & Co. is approved to protect against the Zaire ebolavirus in people 18 and older. (Source: WebMD Health)
Source: WebMD Health - December 20, 2019 Category: Consumer Health News Source Type: news

US approves first Ebola vaccine amid West African outbreak of the deadly disease
On Thursday, the US Food and Drug Administration approved Ervebo, the first vaccine against Ebola to get green lit by American officials. It comes as a Congo outbreak rages on and has killed 4 in Uganda. (Source: the Mail online | Health)
Source: the Mail online | Health - December 20, 2019 Category: Consumer Health News Source Type: news